Could high free testosterone in women be PCOS?

High free testosterone in women can indicate PCOS, but it's not the only cause—other conditions like CAH, Cushing's syndrome, or insulin resistance can also elevate levels. A comprehensive evaluation including symptoms, other hormone tests, and imaging is needed for accurate diagnosis.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Free Testosterone in Women

While testosterone is often considered a male hormone, women naturally produce small amounts in their ovaries and adrenal glands. This hormone plays important roles in female health, including maintaining muscle mass, bone density, libido, and overall energy levels. However, when testosterone levels rise above the normal range, it can signal underlying health conditions that need attention.

Free testosterone refers to the portion of testosterone that isn't bound to proteins in the blood and is therefore biologically active. In women, normal free testosterone levels typically range from 0.3 to 3.7 pg/mL, though this can vary by age and laboratory. When levels exceed this range, it's called hyperandrogenism, which can manifest through various symptoms and may indicate conditions like polycystic ovary syndrome (PCOS).

The Connection Between High Free Testosterone and PCOS

PCOS is one of the most common endocrine disorders affecting women of reproductive age, impacting approximately 6-12% of women worldwide. High androgen levels, including elevated free testosterone, are a hallmark feature of PCOS and part of the diagnostic criteria. In fact, about 60-80% of women with PCOS have elevated androgen levels, making it the most frequent cause of hyperandrogenism in women.

Differential Diagnosis of High Free Testosterone in Women

ConditionTypical Testosterone LevelKey Distinguishing FeaturesDiagnostic Tests
PCOSPCOSMildly to moderately elevatedIrregular periods, polycystic ovaries, gradual onsetLH/FSH ratio, ultrasound, insulin levels
CAHCongenital Adrenal HyperplasiaModerately to severely elevatedEarly puberty, family history, elevated 17-OHP17-hydroxyprogesterone, genetic testing
Cushing'sCushing's SyndromeMildly elevatedCentral obesity, purple striae, easy bruising24-hour urine cortisol, dexamethasone suppression
TumorsAndrogen-Secreting TumorsSeverely elevated (>200 ng/dL)Rapid onset, severe virilizationImaging (CT/MRI), DHEA-S levels

Testosterone levels and symptoms can overlap between conditions, making comprehensive evaluation essential for accurate diagnosis.

The relationship between PCOS and high testosterone is complex and bidirectional. In PCOS, the ovaries produce excess androgens due to hormonal imbalances involving insulin, luteinizing hormone (LH), and follicle-stimulating hormone (FSH). This overproduction of androgens can interfere with normal ovulation, leading to irregular periods and the formation of small cysts on the ovaries. Understanding these hormone levels through comprehensive testing can help identify PCOS early and guide appropriate treatment strategies.

How PCOS Affects Testosterone Production

In women with PCOS, several mechanisms contribute to elevated testosterone levels:

  • Insulin resistance: Present in 50-70% of women with PCOS, insulin resistance causes the pancreas to produce more insulin, which stimulates the ovaries to produce excess testosterone
  • LH/FSH imbalance: Women with PCOS often have an elevated LH to FSH ratio, which triggers increased androgen production in the ovarian theca cells
  • Decreased SHBG: Sex hormone-binding globulin (SHBG) levels are often lower in PCOS, resulting in more free (active) testosterone circulating in the blood
  • Adrenal involvement: Some women with PCOS also have increased androgen production from the adrenal glands

Other Causes of High Free Testosterone in Women

While PCOS is the most common cause of elevated free testosterone in women, it's not the only possibility. Several other conditions can lead to hyperandrogenism, and distinguishing between them is crucial for proper treatment. Here are the main differential diagnoses to consider:

Congenital Adrenal Hyperplasia (CAH)

CAH is a genetic disorder affecting the adrenal glands' ability to produce certain hormones. The most common form, 21-hydroxylase deficiency, leads to excess androgen production. Unlike PCOS, CAH is present from birth and may cause more severe symptoms. Women with non-classic CAH can present similarly to PCOS but typically have very high levels of 17-hydroxyprogesterone.

Cushing's Syndrome

This condition results from prolonged exposure to high cortisol levels. While less common than PCOS, Cushing's syndrome can cause elevated testosterone along with distinctive features like central weight gain, purple stretch marks, easy bruising, and a rounded face. Cortisol testing can help differentiate this condition from PCOS.

Androgen-Secreting Tumors

Though rare, tumors of the ovaries or adrenal glands can produce excess androgens. These typically cause rapid onset of symptoms and very high testosterone levels (usually above 200 ng/dL). Unlike PCOS, which develops gradually, tumor-related hyperandrogenism often presents suddenly with severe symptoms.

Understanding the various causes of elevated testosterone is essential for accurate diagnosis. A comprehensive hormone panel that includes not just testosterone but also other key markers like DHEA-S, cortisol, and SHBG can help healthcare providers determine the underlying cause and develop an appropriate treatment plan.

Symptoms of High Free Testosterone in Women

Elevated free testosterone can manifest through various symptoms, which may develop gradually or appear more suddenly depending on the underlying cause. Recognizing these symptoms early can lead to timely diagnosis and treatment. The most common signs include:

  • Hirsutism: Excess hair growth in male-pattern areas (face, chest, back, abdomen)
  • Acne: Particularly along the jawline and chin, often resistant to typical treatments
  • Male-pattern baldness: Thinning hair at the crown or receding hairline
  • Irregular or absent periods: Due to disrupted ovulation
  • Weight gain: Especially around the midsection
  • Mood changes: Including increased irritability or depression
  • Decreased breast size: In severe cases
  • Deepening of the voice: Rare but possible with very high levels
  • Clitoral enlargement: In cases of severe hyperandrogenism

The severity and combination of symptoms can vary significantly between individuals. Some women may have high testosterone with minimal symptoms, while others experience multiple symptoms even with moderately elevated levels. This variability is partly due to differences in androgen receptor sensitivity and the presence of other hormonal imbalances.

Diagnostic Approach: Beyond Just Testosterone

Diagnosing PCOS requires more than just finding elevated free testosterone. According to the Rotterdam criteria, PCOS diagnosis requires two of the following three features: 1) Oligo-ovulation or anovulation (irregular or absent periods), 2) Clinical or biochemical signs of hyperandrogenism, and 3) Polycystic ovaries on ultrasound. Additionally, other causes of hyperandrogenism must be excluded.

Essential Laboratory Tests

A comprehensive evaluation for suspected PCOS should include:

  • Free and total testosterone: To assess androgen levels
  • SHBG (Sex Hormone-Binding Globulin): Often low in PCOS
  • LH and FSH: To evaluate the LH/FSH ratio (often elevated in PCOS)
  • DHEA-S: To assess adrenal androgen production
  • 17-hydroxyprogesterone: To rule out congenital adrenal hyperplasia
  • Prolactin: To exclude hyperprolactinemia
  • TSH and free T4: To rule out thyroid disorders
  • Fasting glucose and insulin: To assess for insulin resistance
  • Lipid panel: As PCOS increases cardiovascular risk
  • Anti-Müllerian hormone (AMH): Often elevated in PCOS

Regular monitoring of these biomarkers is crucial for women with PCOS or suspected hormonal imbalances. Comprehensive hormone testing can help track treatment effectiveness and identify metabolic changes early, allowing for timely interventions to prevent long-term complications.

Imaging Studies

Transvaginal ultrasound is often performed to look for polycystic ovarian morphology. However, it's important to note that having polycystic-appearing ovaries alone doesn't confirm PCOS diagnosis, as this finding can be present in up to 20% of women without the syndrome. The ultrasound typically shows 12 or more follicles in each ovary or increased ovarian volume.

Treatment Options for High Testosterone and PCOS

Treatment for elevated free testosterone depends on the underlying cause, symptom severity, and individual goals such as fertility. For PCOS specifically, treatment typically involves a multifaceted approach addressing both hormonal imbalances and metabolic dysfunction.

Lifestyle Modifications

Lifestyle changes form the foundation of PCOS management and can significantly improve testosterone levels:

  • Weight loss: Even a 5-10% reduction can improve hormone levels and restore ovulation
  • Regular exercise: Combines cardio and strength training to improve insulin sensitivity
  • Dietary changes: Focus on low-glycemic foods, adequate protein, and healthy fats
  • Stress management: Chronic stress can worsen hormonal imbalances
  • Sleep optimization: Poor sleep affects insulin resistance and hormone production

Medical Treatments

Several medications can help manage high testosterone and PCOS symptoms:

  • Combined oral contraceptives: Suppress ovarian androgen production and increase SHBG
  • Anti-androgens (spironolactone, finasteride): Block testosterone's effects on tissues
  • Metformin: Improves insulin sensitivity and can lower testosterone levels
  • Inositol supplements: May improve insulin sensitivity and reduce testosterone
  • GLP-1 agonists: Newer option for weight loss and metabolic improvement in PCOS

For women trying to conceive, treatments focus on ovulation induction with medications like clomiphene citrate or letrozole, while addressing underlying insulin resistance. Regular monitoring through blood tests helps ensure treatments are working effectively and allows for adjustments as needed.

Long-Term Health Implications

Untreated high testosterone and PCOS can have significant long-term health consequences beyond reproductive issues. Women with PCOS have increased risks for several conditions that require ongoing monitoring and preventive care:

  • Type 2 diabetes: 3-7 times higher risk compared to women without PCOS
  • Cardiovascular disease: Increased risk of hypertension, dyslipidemia, and heart disease
  • Endometrial cancer: Due to unopposed estrogen from chronic anovulation
  • Sleep apnea: More common in women with PCOS, independent of weight
  • Non-alcoholic fatty liver disease: Present in up to 35% of women with PCOS
  • Depression and anxiety: 3-4 times more common in women with PCOS

These increased risks underscore the importance of early diagnosis and comprehensive management. Regular health screenings, including metabolic panels, cardiovascular assessments, and mental health evaluations, should be part of routine care for women with PCOS or persistent hyperandrogenism.

Taking Control of Your Hormonal Health

While high free testosterone in women is often associated with PCOS, it's crucial to remember that proper diagnosis requires comprehensive evaluation. Not every woman with elevated testosterone has PCOS, and not every woman with PCOS will have significantly elevated testosterone. The key is understanding your unique hormonal profile and how it relates to your symptoms and overall health.

If you're experiencing symptoms of high testosterone or have been diagnosed with PCOS, remember that effective treatments are available. Working with healthcare providers who understand the complexity of hormonal health can help you develop a personalized treatment plan. Regular monitoring of your hormone levels and metabolic markers allows you to track progress and make informed decisions about your health.

Early detection and management of hormonal imbalances can prevent long-term complications and significantly improve quality of life. Whether through lifestyle modifications, medical treatments, or a combination of both, taking proactive steps to address high testosterone and its underlying causes empowers you to optimize your health for years to come.

References

  1. Teede, H. J., Misso, M. L., Costello, M. F., et al. (2018). Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Human Reproduction, 33(9), 1602-1618.[Link][PubMed][DOI]
  2. Rosenfield, R. L., & Ehrmann, D. A. (2016). The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocrine Reviews, 37(5), 467-520.[PubMed][DOI]
  3. Azziz, R., Carmina, E., Chen, Z., et al. (2016). Polycystic ovary syndrome. Nature Reviews Disease Primers, 2, 16057.[PubMed][DOI]
  4. Lizneva, D., Suturina, L., Walker, W., et al. (2016). Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertility and Sterility, 106(1), 6-15.[PubMed][DOI]
  5. Escobar-Morreale, H. F. (2018). Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nature Reviews Endocrinology, 14(5), 270-284.[PubMed][DOI]
  6. Carmina, E., & Lobo, R. A. (2018). Comparing Lean and Obese PCOS in Different PCOS Phenotypes: Evidence That the Body Weight Is More Important than the Rotterdam Phenotype in Influencing the Metabolic Status. Diagnostics, 8(4), 76.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my free testosterone at home?

You can test your free testosterone at home with SiPhox Health's Hormone Focus Program, which includes comprehensive hormone testing including testosterone, free testosterone (calculated), SHBG, and other key hormones like LH, FSH, and DHEA-S that help evaluate PCOS and other hormonal conditions.

What is considered high free testosterone in women?

Normal free testosterone levels in women typically range from 0.3 to 3.7 pg/mL, though this can vary by age and laboratory. Levels above this range are considered elevated and may indicate conditions like PCOS, though diagnosis requires comprehensive evaluation including symptoms and other hormone tests.

Can you have high testosterone without having PCOS?

Yes, several conditions besides PCOS can cause high testosterone in women, including congenital adrenal hyperplasia (CAH), Cushing's syndrome, androgen-secreting tumors, and certain medications. Proper diagnosis requires ruling out these other causes through comprehensive testing.

How quickly can testosterone levels change with treatment?

With appropriate treatment, testosterone levels can begin to improve within 2-3 months. Lifestyle changes like weight loss and exercise may take 3-6 months to show significant effects, while medications like oral contraceptives or anti-androgens typically show results within 2-3 menstrual cycles.

Should I test other hormones besides testosterone if I suspect PCOS?

Yes, comprehensive testing is essential for PCOS diagnosis. Important tests include LH, FSH, DHEA-S, SHBG, prolactin, thyroid hormones, and metabolic markers like fasting glucose and insulin. This broader panel helps confirm PCOS and rule out other conditions that can mimic its symptoms.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details